Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
reLIMS is a healthcare and scientific laboratory software company centered on a cloud-based laboratory information management system (LIMS) used by clinical and testing laboratories. The platform is designed to manage the sample lifecycle, automate laboratory workflows, interface with instruments and external systems, support reporting, and improve compliance, security, and auditability. Public descriptions indicate use cases across clinical pathology, toxicology, molecular, genetics, COVID-19 and infectious disease testing, as well as cannabis, hemp, agriculture, and soil testing laboratories. The company appears to have operated from Redwood City, California and has been associated with founder and CEO Anita Manwani. reLIMS is now part of Clinisys, indicating the business or product has been acquired and integrated into a larger laboratory software portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on reLIMS.